PODCAST · health
DKBmed Radio
by DKBmed
DKBmed Radio provides health care clinicians with expert insight and analysis in a wide variety of disease states and specialty areas. Earn continuing medical education (CME) credit by listening to the episode and visiting our website linked in the episode description. Visit https://dkbmed.com/ for more information and CME opportunities. Hosted on Acast. See acast.com/privacy for more information.
Episodes
-
Dialogues in Obesity: Where Visionaries Meet to Lead the Change
Episode 2: The Role of Pharmacotherapy for Treatment of Obesity Hosted on Acast. See acast.com/privacy for more information.
-
Dialogues in Obesity: Where Visionaries Meet to Lead the Change
Episode 1: Obesity as a Chronic Disease Hosted on Acast. See acast.com/privacy for more information.
-
Overcoming Barriers to PrEP in Rural America
PrEP. For most patients, that’s a simple drug regimen that can be prescribed after a negative HIV screen. Safe. Effective. Proactive protection to stop the spread of HIV infection in MSM, cisgender, and transgender individuals. Post-test for CME credits: https://elit.dkbmed.com/issues/228/test...
-
Cystic Fibrosis Life Transitions
Until the advent of highly effective CFTR modulator medications, cystic fibrosis was considered a pediatric disease, because most individuals did not survive into adulthood. Now, with more adults living with CF than children, priorities must change. In these interviews, we discuss what…
more -
New Directions in Long-Acting ART and Long-Acting PrEP
How will the current research advancements in long-acting ART affect clinicians’ ability to provide better care for their patients with HIV? The recent data show that the low uptake and adherence to PrEP may be largely due to the pill burden and potential stigma of daily dosing. How might the…
more -
Barriers To Minority Participation in MS Clinical Trials
In the clinical trials of new MS medications and procedures, why has the participation of racial and ethnic minority individuals been so low? Is it a difficulty with outreach? Are the patient barriers to participation underrecognized and underaddressed? Does historical mistrust of the medical...
-
Treating Sexual & Bladder Dysfunction in Patients with MS
The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage…
more -
Promising New Options in MS Care
The long-anticipated advances in therapeutic treatments to improve outcomes in both relapsing and progressive MS are coming closer to fruition. Although much of the evidence is still preclinical, the variety and scope of the ongoing research promises to provide new and novel options to manage…
more -
PLWH & SUD: A Clinical Perspective
The primary health concern for all individuals living with HIV should be managing their disease, particularly maintaining adherence to their ART treatment. Yet for many, the more immediate demands of their substance use disorder — whether for stimulants and/or opioids — take precedence and can...
-
What's New with the Flu? 2024-2025 Respiratory Season Update
CLAIM CME/CE CREDIT HERE: https://dkbmed.com/programs/209/sections/122/evaluation Influenza remains a perennial public health threat, and urgent and convenient care providers serve an essential role in treating patients who become infected with the virus. This webinar will help you recognize...
-
MS and Family Planning: The Clinician’s Perspective
Giving birth and raising a family. For many people with MS, the path to achieving those goals contains more questions than answers. Questions about timing — which should come first, pregnancy or disease stability on a DMT? Questions about genetics — can MS be passed on to the baby? Questions…
more -
PLWH: Overcoming Post-Incarceration Care Disengagement
People living with HIV who’ve had criminal legal involvement face significant challenges that complicate their ability to remain in the HIV care continuum. Many, while incarcerated, have stopped treatment, and once back in the community have been reluctant to resume ART. Why? What are the key...
-
Clinical Approaches to MS Fatigue
In this issue: Fatigue. It’s one of the most common complaints providers hear from their patients with MS. It interferes with virtually every aspect of a patient’s life. What can clinicians do to better identify MS fatigue? And what do they need to know to better provide management effectively...
-
POMS: A Clinical View
In this issue: POMS. Pediatric Onset Multiple Sclerosis: children and adolescents with symptoms indicating a diagnosis of multiple sclerosis. Are their presentations different from adult-onset MS? POMS is often associated with higher degrees of activity and inflammation early in the disease. How...
-
Managing HIV in an Aging Population
Widespread use of highly effective ART has increased the life expectancy of people living with HIV (PLWH) to close to that of the general population. But despite highly effective viral suppression, the risks for cardiovascular diseases continue to increase in these individuals. So too do the…
more -
Managing HIV Coinfections: HBV and TB
Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection. Post-test for CME credits:...
-
ART, HRT, Pregnancy, and Menopause in Women Living With HIV
Pregnancy and menopause — for many women, these are two of the most significant healthcare events in their lives. For WLWH (women living with HIV) and their healthcare providers, managing these life-changing periods is often complicated by many questions. Post-test for CME credits:...
-
Clinical Management Considerations in Mild Asthma
Mild asthma. For patients showing wheezing and shortness of breath on moderate exertion, it’s one of the most common diagnoses, even when breath sounds are clear and pulmonary function testing is normal. What makes mild asthma “mild”? The key guidelines base the stage of a patient’s asthma on how...
-
PH in the Clinic: The Revised WHO Classifications
Pulmonary hypertension. The 2022 ESC/ERS revised guidelines have redefined it. New evidence from ongoing and completed clinical trials have led to updates in diagnostic thresholds and treatment algorithms. New agents — some approved, others advancing through the pipeline — promise improved…
more -
Clinical Approaches to Marginalized Populations
In part 1 of this eHIV Review Special Edition (still available at eHIVreview.org), eHIV Review Program Director Justin Alves, Nurse Educator at Boston Medical Center, reviewed the recent evidence describing some of the barriers to care experienced by marginalized individuals at risk for or living...
-
Addressing the Needs of Marginalized Populations - Mehtani
Marginalized individuals at risk for or living with HIV — the formerly incarcerated, immigrants, people with unstable housing, residents of rural communities, the rising number with substance use disorder — have long faced disparities in obtaining adequate health care. What do HCPs need to know…
more -
Addressing the Needs of Marginalized Populations - Loukas
Marginalized individuals at risk for or living with HIV — the formerly incarcerated, immigrants, people with unstable housing, residents of rural communities, the rising number with substance use disorder — have long faced disparities in obtaining adequate health care. What do HCPs need to know…
more -
HIV Stigma: A Psychologist’s Viewpoint
A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum?...
-
Using the New Biomarkers in Clinical Practice
NfL — neurofilament light, from the blood, not the CSF. Is it a reliable indicator of MS activity, a predictor of relapse-related disability, and a monitor of treatment efficacy? OCT — optical coherence tomography. Fast, safe, reliable, and repeatable, it can reveal the cellular layers inside the...
-
AYA and Ending the HIV Epidemic
A wealth of evidence confirms that adolescents and young adults (AYA) are indeed a priority population whose needs must be addressed for the US Ending the HIV Epidemic program to be successful. What do providers need to know about AYA to bring more of these patients into the HIV care continuum?...
-
Emerging MS Clinical Options
Has the place for BTK inhibitors in MS been determined? How well do extended interval or alternative B cell depletion dosing regimens work, and for which patients? Do the data support HSCT (hematopoietic stem cell transplant) over high-efficacy DMT — again, for which patients, and with what...
-
Clinical and Radiologic Features of an MS Prodrome
What’s the evidence supporting the existence of an MS prodromal phase — where the biology of the disease has begun but the symptoms typical of MS have not yet appeared? Are there biomarkers to help identify it? Imaging abnormalities? And how can diagnosing a prodrome benefit patients? Join us as…
more -
Mitigating MS DMT Infection Risk
Clinicians prescribing the increasingly higher efficacy B-cell depletion or S1P modulators therapies — how aware are they of the newer concerns about safety? Which of their patients may be in greater danger of acquiring PML and/or opportunistic infections? The vaccinations commonly recommended…
more -
Delivering High-Quality HIV Care to Cisgender and Transgender Women
Why do cisgender and transgender women, and particularly women of color, account for such a disproportionate percentage of HIV infections in the US? Why are so many so reluctant to accept PrEP? What can clinicians do to bridge this critical gap in essential HIV services? These are some of the...
-
Overcoming Barriers to MS Care
Too many individuals with MS are not receiving access to the most effective care. Why? What’s behind these disparities? And what can individual clinicians do to help remove the barriers that prevent equitable care for all patients?Join us, as Dr. Dorlan Kimbrough, from the division of Neurology,...
-
Newer NNRTI Agents in Clinical Practice
Non-nucleoside reverse transcriptase inhibitors (NNRTIs). Rilpivirine, in combination with cabotegravir, provides a long-acting injectable option for both treatment and PrEP. But what risk factors have been associated with virologic failure? Doravirine appears to provide a favorable impact on...
-
Clinical Opinions: Managing Spasticity in Individuals with MS
How burdensome is spasticity for patients with MS? What’s the approach to treatment, and how effective is it? What do patients and clinicians need to know about cannabis-based therapies? These are the key questions Program Director Dr. Michael Kornberg from the Johns Hopkins School of Medicine...
-
Emerging HIV Therapies and Potential Clinical Uses
Hosted on Acast. See acast.com/privacy for more information.
-
Hepatitis B: Our Current Understanding
Hepatitis B. It may not be curable yet, but as our knowledge continues to grow, so does our ability to benefit our patients today as we prepare them for tomorrow. That’s the focus of this Special HBV Edition of eViralHepatitis Review. The first part of this program presented an evidence-based...
-
MS Risk Factors and Outcomes
In her Expert Commentary, Dr. Melanie Ward from West Virginia University’s Rockefeller Neuroscience Institute provided analysis of the newer data describing the modifiable and nonmodifiable risk factors for developing MS and/or increasing the rate of disease progression and disability. Join us…
more -
1/26/2023 - COVID-19 Subvariants XBB and XBB.1.5
Dr. Paul Auwaerter discusses XBB and XBB.1.5 subvariants and the respiratory virus season. Topics: *Why XBB and XBB.1.5 subvariants are more transmissible than other subvariants, but less virulent *Effect of Paxlovid on hospitalization and mortality *Summary of the flu and RSV season *Deciding…
more -
Stigma and HIV Care in LGBTQ+ Persons
Stigma. What is it, and where does it come from? How do LGBTQ+ individuals, particularly those with HIV, experience it? How does stigma affect their mental health? What effect does it have on their engagement in HIV care? What do health care providers need to change to minimize stigma in their...
-
CF and Diet and Nutrition: The Changing Paradigm
Individuals with cystic fibrosis — adults as well infants and children — have long struggled to gain and maintain their weight. But how has the current widespread use of highly effective modulator treatments — HEMT — changed that situation? That’s the focus of this eCysticFibrosis Review Special...
-
Newer Options for Treatment-Experienced Patients Podcast
Treatment-experienced patients with RAMs — resistance-associated mutations — remain a difficult management challenge. Every case of HIV drug resistance requires a therapeutic regimen individualized for each patient’s ART history. How will new and in-development agents affect the equation? Which...
-
Effects of Race/Ethnicity on MS Diagnosis and Treatment
How aware are clinicians that MS should no longer be considered a “White people only” disease? What roles have race and ethnicity been shown to play in MS disease severity and disability progression? What do health care professionals need to know to provide the most effective care for all their...
-
ETI (CFTR Triple Therapy): Clinical Opportunities
The advent of triple CFTR modulator therapy – ETI (elexacaftor/tezacaftor/ivacaftor) — poses a number of clinical questions. Are three agents really better than two? For which patients, in what circumstances? What does the CF Team need to understand to ensure their patients get maximum benefit?...
-
Weight Gain in PLWH: A Clinical Concern
Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain?…
more -
Clinical Considerations for In-Development MS Treatments
Where’s the newer MS research leading? How has our understanding of noninflammatory progressive MS changed? How might these findings affect what happens in the clinic? Join us as we discuss these and other questions with Dr. Michael Kornberg from the Johns Hopkins School of Medicine in this...
-
8/10/2022 - COVID-19 Testing Interview Part 2
Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 testing. Topics: *Why are we seeing prolonged antigen positive test results? *Do we know when someone is infectious? For how long? *Speculating on the cause of Paxlovid rebound Post-test for CME/CE credit:...
-
7/28/2022 - COVID-19 Immunity Interview Part 1
Dr. Paul Auwaerter interviews Dr. Michael Mina about COVID-19 immunity. Topics: *Is COVID-19 here to stay? *Immunity evasiveness of Omicron BA.4 and BA.5 *Expectations for the fall and winter 2022 *Thoughts on upcoming booster reformulation *Should you get a booster now or wait? Post-test for...
-
Is that MS Diagnosis Accurate?
Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags — warnings that something about the patient’s condition does not meet the accepted MS diagnostic criteria — that need to be investigated? Join us in this...
-
Nonpharmacologic Symptom Management
In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What doesn’t? What does the evidence say? Join…
more -
COVID-19: The Morbidity/Mortality Risk
Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)? Join Clinical Research Nurse Diane Kanjilal, manager of the...
-
COVID-19: Then and Now
What was it like for a frontline critical care pulmonologist at the very beginning of the COVID-19 epidemic? On the frontlines as the epidemic became pandemic? What’s it like today, with new variants and new in-patient and out-patient treatments? What are the key differences between then and now,...
-
Pulmonary Exacerbations and IV Antibiotics
Managing pulmonary exacerbations in people with cystic fibrosis: is there high-grade evidence to support best practices? How helpful is the most current guidance? Does the recent research challenge the current standard of care? Join us for this eCysticFibrosis Review podcast, as Dr. D.B. Sanders...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
DKBmed Radio provides health care clinicians with expert insight and analysis in a wide variety of disease states and specialty areas. Earn continuing medical education (CME) credit by listening to the episode and visiting our website linked in the episode description. Visit https://dkbmed.com/ for more information and CME opportunities.
Hosted on Acast. See acast.com/privacy for more information.
HOSTED BY
DKBmed
Loading similar podcasts...
Frequently Asked Questions
How many episodes does DKBmed Radio have?
DKBmed Radio currently has 222 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is DKBmed Radio about?
DKBmed Radio provides health care clinicians with expert insight and analysis in a wide variety of disease states and specialty areas. Earn continuing medical education (CME) credit by listening to the episode and visiting our website linked in the episode description. Visit https://dkbmed.com/ for...
How often does DKBmed Radio release new episodes?
DKBmed Radio publishes regularly with 222 episodes available. Check the episode list for the typical release schedule.
Where can I listen to DKBmed Radio?
You can listen to DKBmed Radio on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts DKBmed Radio?
DKBmed Radio is created and hosted by DKBmed.
URL copied to clipboard!